17-beta-hydroxysteroid dehydrogenase deficiency natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{17-beta-hydroxysteroid dehydrogenase deficiency}}
{{17-beta-hydroxysteroid dehydrogenase deficiency}}
Originally described in 1971 by Saez and his colleagues, the characteristic phenotype at birth is an XY individual with female or ambiguous external genitalia (3,4). Testes may be undescended or located in the inguinal canal or labia majora. The majority of those affected have female external genitalia and consequently are raised as girls (1). Two interesting features of this disease are the presence of Wolffian duct derivatives (epididymus, vas deferens, and seminal vesicles) and the progressive virilization at the time of puberty, both of which depend on the action of testosterone
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 09:01, 23 March 2022

17-beta-hydroxysteroid dehydrogenase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Molecular Genetic Studies

Genotyping

X Ray

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

17-beta-hydroxysteroid dehydrogenase deficiency natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 17-beta-hydroxysteroid dehydrogenase deficiency natural history, complications and prognosis

CDC on 17-beta-hydroxysteroid dehydrogenase deficiency natural history, complications and prognosis

17-beta-hydroxysteroid dehydrogenase deficiency natural history, complications and prognosis in the news

Blogs on 17-beta-hydroxysteroid dehydrogenase deficiency natural history, complications and prognosis

Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency

Risk calculators and risk factors for 17-beta-hydroxysteroid dehydrogenase deficiency natural history, complications and prognosis

Originally described in 1971 by Saez and his colleagues, the characteristic phenotype at birth is an XY individual with female or ambiguous external genitalia (3,4). Testes may be undescended or located in the inguinal canal or labia majora. The majority of those affected have female external genitalia and consequently are raised as girls (1). Two interesting features of this disease are the presence of Wolffian duct derivatives (epididymus, vas deferens, and seminal vesicles) and the progressive virilization at the time of puberty, both of which depend on the action of testosterone

References

Template:WH Template:WS